Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C121 - Neurologic Consultations in Cancer Patients

Wednesday 04/06/22
07:00 AM - 09:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Roy E. Strowd, III, MD, FAAN
Neuro-oncology
Participants will identify the common and rare long-term neurological complications that occur in patients with a systemic malignancy including posterior reversible encephalopathy, progressive multifocal leukoencephalopathy, leptomeningeal metastasis, and chemotherapy induced peripheral neuropathy; Describe the work up and approach to managing long-term survivors of brain cancer who present with new neurological deficit including post-treatment vasculopathy, myelopathy, or radiation induced malignancy
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT Introduction Introduction
Roy E. Strowd, III, MD, FAAN
07:00 AM - 07:00 AM PDT Speaker Walk-in Slides
Roy E. Strowd, III, MD, FAAN
07:05 AM - 07:45 AM PDT Speaker Common Calls from the Cancer Center: Neurological Symptoms in Patients with Systemic Malignancy
Amy A. Pruitt, MD, FAAN
07:45 AM - 08:25 AM PDT Speaker From Horses to Zebras: Neurological Syndromes in Late Survivors of Primary Brain Tumors
Alyx B. Porter, MD, FAAN
08:25 AM - 08:55 AM PDT Discussion Clinical Cases: Review of Neurological Complications in Cancer Patient Cases
Roy E. Strowd, III, MD, FAAN
08:55 AM - 09:00 AM PDT Closing Remarks Conclusion
Roy E. Strowd, III, MD, FAAN
Faculty Disclosures
Amy A. Pruitt, MD, FAAN Dr. Pruitt has nothing to disclose.
Alyx B. Porter, MD, FAAN Dr. Porter has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities.
Roy E. Strowd, III, MD, FAAN Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.